Recall | Medicines | 23/03/2018

The marketing authorization holder has informed its supplied customers in a letter dated 23.03.2018 that increased anaphylactic reactions have been reported after administration of an identical product in France. For this reason, the above mentioned batches are recalled as a precautionary measure.

Name of the medicinal product Inutest 25 % Ampullen
Marketing authorisation number(s) 12687
Marketing authorisation holder Fresenius Kabi Austria GmbH
Batch number(s) 11144222
Classification of the recall1
BASG reference number INS-640.001-2496

Further inquiry note